Establishment Labs Holdings Inc. (ESTA)

NasdaqCM · Medical Devices

69.55
+0.22 (+0.32%)
Updated Sep 1, 8:28 PM ET
AI Rating
Sell
Overall Score
33
Trend
37
Momentum
20
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Establishment Labs Holdings Inc. is trading at $69.55, up 0.32% on the session. The 50 day average sits at $84.91 and the 200 day at $73.15, which puts the stock in a uptrend. RSI is at 30.6, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $70.36 with resistance near $81.33, so that band frames the current range. Average daily movement is roughly $3.41, or about 4.9% of the share price, which is what any stop placement has to allow for. The overall health score of 33 out of 100 combines a trend score of 37, momentum of 20 and a risk score of 46.

Technical indicators

RSI (14)
30.6
weak
MACD
-4.146
bearish crossover
SMA 20
77.28
SMA 50
84.91
SMA 200
73.15
uptrend
ATR (14)
3.41
avg daily range
Support
70.36
Resistance
81.33
Volume vs 20d
0.54x
below average
Volatility
61.0%
annualised
1 month
-24.43%
3 months
-0.07%

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.